Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable

被引:128
作者
Hu, Rong
Khor, Tin Oo
Shen, Guoxiang
Jeong, Woo-Sik
Hebbar, Vidya
Chen, Chi
Xu, Changjiang
Reddy, Bandaru
Chada, Kiran
Kong, Ah-Ng Tony [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Chem Biol, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA
[4] Inje Univ, Coll Biomed Sci & Engn, Sch Food & Life Sci, Inst Food Sci, Gimhae, Gyeongnam, South Korea
关键词
D O I
10.1093/carcin/bgl049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sulforaphane (SFN) is an isothiocyanate that is present abundantly in widely consumed cruciferous vegetables and has a particularly high content in broccoli and cauliflower. It has been shown to be an effective inhibitor of some carcinogen-induced cancers in rodents. Here, we investigated the chemopreventive efficacy of SFN in the ApcMin/+ mouse model. ApcMin/+ mice were fed with diet supplemented with two different dose levels of SFN (300 and 600 p.p.m.) for 3 weeks. Our results clearly demonstrated that ApcMin/+ mice fed with SFN-supplemented diet developed significantly less and smaller polyps with higher apoptotic and lower proliferative indices in their small intestine, in a SFN dose-dependent manner. In addition, immunohistochemical (IHC) staining of the adenomas indicated that SFN significantly suppressed the expression of phosphorylated c-Jun N-terminal kinase (p-JNK), phosphorylated extracellular signal-regulated kinases (p-ERK) and phosphorylated-Akt (p-Akt), which were found to be highly expressed in the adenomas of ApcMin/+ mice. In contrast, expression of two important biomarkers of the Wnt signaling pathway, beta-catenin and cyclin-D1 was unaffected by SFN treatment. Measurement of SFN and its metabolite SFN-GSH in the small intestine using LC-MS indicates that the concentrations between 3 and 30 nmol/g are required to prevent, or retard adenoma formation in the gastrointestinal tract of ApcMin/+ mice.
引用
收藏
页码:2038 / 2046
页数:9
相关论文
共 40 条
[1]   Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study [J].
Andreyev, HJN ;
Norman, AR ;
Cunningham, D ;
Oates, JR ;
Clarke, PA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (09) :675-684
[2]   Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis [J].
Arber, N ;
Hibshoosh, H ;
Moss, SF ;
Sutter, T ;
Zhang, Y ;
Begg, M ;
Wang, SB ;
Weinstein, IB ;
Holt, PR .
GASTROENTEROLOGY, 1996, 110 (03) :669-674
[3]   EphB receptor activity suppresses colorectal cancer progression [J].
Batlle, E ;
Bacani, J ;
Begthel, H ;
Jonkeer, S ;
Gregorieff, A ;
van de Born, M ;
Malats, N ;
Sancho, E ;
Boon, E ;
Pawson, T ;
Gallinger, S ;
Pals, S ;
Clevers, H .
NATURE, 2005, 435 (7045) :1126-1130
[4]  
Bonnesen C, 2001, CANCER RES, V61, P6120
[5]   A survival-stratification model of human colorectal carcinomas with β-catenin and p27kip1 [J].
Cheah, PY ;
Choo, PH ;
Yao, J ;
Eu, KW ;
Seow-Choen, F .
CANCER, 2002, 95 (12) :2479-2486
[6]  
Chiao JW, 2002, INT J ONCOL, V20, P631
[7]   Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate [J].
Chung, FL ;
Conaway, CC ;
Rao, CV ;
Reddy, BS .
CARCINOGENESIS, 2000, 21 (12) :2287-2291
[8]   Therapeutics targeting signal transduction for patients with colorectal carcinoma [J].
de Bono, JS ;
Rowinsky, EK .
BRITISH MEDICAL BULLETIN, 2002, 64 :227-254
[9]  
Dicuonzo G, 2001, CLIN CANCER RES, V7, P4049
[10]   Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells [J].
Dihlmann, S ;
Kloor, M ;
Fallsehr, C ;
Doeberitz, MV .
CARCINOGENESIS, 2005, 26 (09) :1503-1512